Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine–induced injury in human internal thoracic artery

This publication has 19 references indexed in Scilit:

• AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats
  British Journal of Pharmacology, 2011
• Effect of Amlodipine in Human Internal Mammary Artery and Clinical Implications
  The Annals of Thoracic Surgery, 2010
• Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis
  European Heart Journal, 2009
• Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling
  The Journal of Pharmacology and Experimental Therapeutics, 2008
• Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients With Chronic Heart Failure
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
• Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes
  Diabetes Care, 2007
• Probucol Decreases Asymmetrical Dimethylarginine Level by Alternation of Protein Arginine Methyltransferase I and Dimethylarginine Dimethylaminohydrolase Activity
  Cardiovascular Drugs and Therapy, 2006
• L-4F, an Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation in Hypercholesterolemia and Sickle Cell Disease
  Circulation, 2003
• NO at work
  Cell, 1994
• Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
  The Lancet, 1992